BioActs

BioActs has developed the AngioFlamma® series as an effective fluorescent probe for detecting angiogenesis and tumor cells. BioActs is a leading innovator committed to a healthier world. Our dedicated team of researchers is passionate about developing and synthesizing fluorescent materials for optical imaging and medical diagnostics, as well as optical contrast agents for animal model studies.